TNFSF10 and cancer: Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) specifically targets cancer cells while sparing normal cells, making it a desirable target to avoid many of the off-target side effects that are common with chemotherapy [72].